Skip to main content

News

By Jeff Lagasse | 11:58 am | February 22, 2022
The funding is for organizations working to address the upstream social determinants of health impacting the likelihood of developing diabetes.
By Susan Morse | 11:12 am | February 22, 2022
There could be "dangerous and unnecessary gaps in coverage and care," groups tell Congress.
By Jeff Lagasse | 04:19 pm | February 21, 2022
This spending growth resulted from strong federal support in 2020 and waning support in 2021, the numbers showed.
By Jeff Lagasse | 12:34 pm | February 21, 2022
The move was made to avoid potential staffing issues and to give healthcare workers more time to comply.
By Susan Morse | 12:16 pm | February 21, 2022
The DOJ is reportedly preparing the lawsuit to block the deal.
By Jeff Lagasse | 04:04 pm | February 18, 2022
The expectation is that customers will be able to minimize the risk of missing rebate program revenue targets and receive rebate funds more quickly.
By Jeff Lagasse | 11:05 am | February 18, 2022
Costs per single treatment for drugs administered in hospitals were an average of $7,000 more than those purchased through specialty pharmacies.
By Susan Morse | 10:04 am | February 18, 2022
Mayo Clinic is able to send kidney and marrow transplant patients home to recover to a hospital level of care, says Medically Home CEO Rami Karjian.
By Susan Morse | 08:28 pm | February 17, 2022
Rhode Island will join the Federal Trade Commission's lawsuit to block the merger.
By Jeff Lagasse | 04:50 pm | February 17, 2022
With specialty drug costs projected to reach $505 billion by 2023 by the company's estimates, Optum has tapped into a potential market opportunity.